ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.884,75
-0,57%
S&P 500
5.930,85
1,09%
Dow Jones
42.840,26
1,18%
Euro vs US Dollar
1,043
0,00%
Bitcoin
96.511,01
-0,72%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. Sol Gel Technologies Ltd (SLGL) Börsenkurse

Sol Gel Technologies Ltd

Sol Gel Technologies Ltd (SLGL)

NASDAQ
0,429
-0,0112
(-2,54%)
Geschlossen 22 Dezember 10:00PM
Verzögert um 15 Minuten
0,4298
0,0008
(0,19%)
Nach Börsenschluss: 1:59AM
Verzögert um 15 Minuten

Professionelle Tools für Privatanleger.

Premium

Wichtige Statistiken und Details

Current Price
0,429
Gebot
0,405
Fragen
0,51
Volumen
48.614
0,411 Tagesbereich 0,479899
0,334 52-Wochen-Bereich 1,5754
Marktkapitalisierung
11,951M
Handelsende
0,4402
Handelsbeginn
0,4409
Letzte Trade
503
@
0.429
Letzter Handelszeitpunkt
Finanzvolumen
US$ 20.882
VWAP
0,429551
Durchschnittliches Volumen (3 Mio.)
55.551
Ausgegebene Aktien
27.857.620
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,44
Gewinn pro Aktie (EPS)
-0,98
Erlöse
1,61M
Nettogewinn
-27,24M

Über Sol Gel Technologies Ltd

Sol-Gel Technologies Ltd is a clinical-stage specialty pharmaceutical company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline consists of silica-based microencapsulati... Sol-Gel Technologies Ltd is a clinical-stage specialty pharmaceutical company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline consists of silica-based microencapsulation technology platform, and several generic product candidates across multiple indications. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
www.sol-gel.com
Hauptsitz
Ness Ziona, Center, Isr
Gegründet
-
Sol Gel Technologies Ltd is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker SLGL. The last closing price for Sol Gel Technologies was US$0,44. Over the last year, Sol Gel Technologies shares have traded in a share price range of US$ 0,334 to US$ 1,5754.

Sol Gel Technologies currently has 27.857.620 shares in issue. The market capitalisation of Sol Gel Technologies is US$12,26 million. Sol Gel Technologies has a price to earnings ratio (PE ratio) of -0.44.

SLGL Neueste Nachrichten

Weitere Nachrichten

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

20 November 2024
Edgar (US Regulatory)

Sol-Gel Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Requirement

NESS ZIONA, Israel, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a dermatology company, pioneering treatments for patients with severe skin conditions, conducting...

20 November 2024
GlobeNewswire Inc.

Form 424B3 - Prospectus [Rule 424(b)(3)]

15 November 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

15 November 2024
Edgar (US Regulatory)

Sol-Gel Reports Third Quarter 2024 Financial Results and Provides Corporate Updates

Mori Arkin's appointment as interim CEO as of January 1, 2025 approved by shareholdersPhase 3 clinical trial of SGT-610 for Gorlin Syndrome is ongoing with over 40 clinical sites activatedSGT-210...

15 November 2024
GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

04 November 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

25 September 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

27 August 2024
Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]

19 August 2024
Edgar (US Regulatory)

Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]

19 August 2024
Edgar (US Regulatory)
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.0372-7.979407979410.46620.510.4298314120.46545318CS
4-0.091-17.50.520.67690.4298518320.51944324CS
12-0.251-36.91176470590.680.750.4181555510.56371947CS
26-0.4499-51.18898623280.87890.970.3342219620.51015545CS
52-0.621-59.14285714291.051.57540.3341281630.56872064CS
156-6.761-94.0333796947.198.510.334516801.27567305CS
260-9.491-95.67540322589.9226.520.334486715.06807366CS

SLGL - Frequently Asked Questions (FAQ)

What is the current Sol Gel Technologies share price?
The current share price of Sol Gel Technologies is US$ 0,429
How many Sol Gel Technologies shares are in issue?
Sol Gel Technologies has 27.857.620 shares in issue
What is the market cap of Sol Gel Technologies?
The market capitalisation of Sol Gel Technologies is USD 12,26M
What is the 1 year trading range for Sol Gel Technologies share price?
Sol Gel Technologies has traded in the range of US$ 0,334 to US$ 1,5754 during the past year
What is the PE ratio of Sol Gel Technologies?
The price to earnings ratio of Sol Gel Technologies is -0,44
What is the cash to sales ratio of Sol Gel Technologies?
The cash to sales ratio of Sol Gel Technologies is 7,44
What is the reporting currency for Sol Gel Technologies?
Sol Gel Technologies reports financial results in USD
What is the latest annual turnover for Sol Gel Technologies?
The latest annual turnover of Sol Gel Technologies is USD 1,61M
What is the latest annual profit for Sol Gel Technologies?
The latest annual profit of Sol Gel Technologies is USD -27,24M
What is the registered address of Sol Gel Technologies?
The registered address for Sol Gel Technologies is 7 GOLDA MEIR ST., WEIZMANN SCIENCE PARK, NESS ZIONA, CENTER, 7403650
What is the Sol Gel Technologies website address?
The website address for Sol Gel Technologies is www.sol-gel.com
Which industry sector does Sol Gel Technologies operate in?
Sol Gel Technologies operates in the PHARMACEUTICAL PREPARATIONS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
MYSZMy Size Inc
US$ 4,2001
(211,12%)
121,03M
NVNINVNI Group Ltd
US$ 8,26
(209,36%)
78,06M
TPICTPI Composites Inc
US$ 2,45
(100,82%)
34M
ICGIntchains Group Ltd
US$ 8,77
(88,60%)
527,94k
HSDTHelius Medical Technologies Inc
US$ 0,884851
(84,34%)
121,95M
CYNCYNGN Inc
US$ 0,4603
(-71,41%)
27,91M
MTEMMolecular Templates Inc
US$ 0,1502
(-57,09%)
8,75M
PRFXPainReform Ltd
US$ 5,15
(-53,85%)
2,94M
GALTGalectin Therapeutics Inc
US$ 1,03
(-48,50%)
9,27M
BCABBioAtla Inc
US$ 0,6923
(-41,82%)
6,25M
EDBLEdible Garden AG Inc
US$ 0,24
(65,06%)
354,33M
NVDANVIDIA Corporation
US$ 134,70
(3,08%)
310,19M
APTOAptose Biosciences Inc
US$ 0,28
(64,51%)
306,25M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,606999
(6,49%)
293,22M
PLTRPalantir Technologies Inc
US$ 80,55
(8,54%)
281,23M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
SLGL
Sol Gel Technologies
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten